Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN32841168
ISRCTN32841168
Completed
未知

Prediction of medication response in children with Attention Deficit Hyperactivity Disorder (ADHD): Electroencephalogram (EEG) differences between responders and non-responders to methylphenidate

trecht Institute for Pharmaceutical Sciences (The Netherlands)0 sites50 target enrollmentJuly 16, 2007
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsMedication response in children with Attention Deficit Hyperactivity Disorder (ADHD)Mental and Behavioural DisordersHyperkinetic disorders

Overview

Phase
未知
Intervention
Not specified
Conditions
Medication response in children with Attention Deficit Hyperactivity Disorder (ADHD)
Sponsor
trecht Institute for Pharmaceutical Sciences (The Netherlands)
Enrollment
50
Status
Completed
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 16, 2007
End Date
August 31, 2007
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
trecht Institute for Pharmaceutical Sciences (The Netherlands)

Eligibility Criteria

Inclusion Criteria

  • •1\. Diagnosed with ADHD combined type (no primary diagnoses of attention deficit) according to Diagnostic and Statistic Manual of mental disorders \- fourth edition \- criteria (DSM IV, APA 1994\)
  • •2\. They have (no history of) anxiety disorder, depression, tics, psychosis or autism
  • •3\. Their age is ranged between 7 and 12
  • •4\. Intelligence Quotient (IQ) is above 75
  • •5\. They are free from psychoactive medication
  • •6\. They are free from methylphenidate at least 48 hours before testing
  • •7\. They have no known cardiovascular disease
  • •8\. Normal static binocular acuity, corrected or uncorrected
  • •9\. Written informed consent from the parents

Exclusion Criteria

  • •1\. IQ is below 75
  • •2\. One or more of the following co\-morbid disorders are diagnosed:
  • •2\.1\. Anxiety disorder
  • •2\.2\. Depression
  • •2\.3\. Tics
  • •2\.4\. Psychosis
  • •2\.5\. Autism
  • •3\. Prior enrolment in the same study
  • •4\. Participation in another clinical trial simultaneously
  • •5\. Familiar with epileptic disorders

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Prediction of medication response in children with ADHD: EEG differences between responders and non-responders to methylphenidate.ADHD, methylphenidate response, EEG, DNA, CANTAB, spatial span, spatial working memory, stop-task, CPT, theta/beta ratio
NL-OMON26488trecht Institute for Pharmaceutical Sciences, Utrecht University50
Recruiting
Not Applicable
Early prediction of treatment response in children with Inflammatory Bowel Disease with Intestinal Ultrasound
NL-OMON51551Academisch Medisch Centrum120
Active, not recruiting
Not Applicable
Premedication in paediatric patients: Dose finding study of clonidine administrated as nasal aerosol.
EUCTR2008-000714-74-SEInstitution of Paediatric Anaesthesia and intensiv care, Astrid Lindgren Childrens Hospital, Karolin
Active, not recruiting
Phase 1
Follow-Up study in Previously Treated Children to investigate a new FVIII concentrate
EUCTR2011-001785-17-PLOctapharma AG50
Active, not recruiting
Phase 1
Follow-Up study in Previously Treated Children to investigate a new FVIII concentrateSevere Haemophilia AMedDRA version: 14.0Level: LLTClassification code 10018938Term: Haemophilia A (Factor VIII)System Organ Class: 10010331 - Congenital, familial and genetic disordersTherapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
EUCTR2011-001785-17-CZOctapharma AG60